October 17, 2013
CSIMC Expert Subcommittee on NHI Drug Pricing Affairs The Central Social Insurance Medical Council’s (CSIMC) drug pricing subcommittee roughly agreed on October 16 to introduce a new indicator to evaluate whether the premium for new drug development has actually resulted...read more